Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMBATAC: Cetuximab, CRS, and HIPEC in K-ras Wild-Type Colorectal Cancer
NCT01540344Phase 2Terminated
- Sponsor
- University of Regensburg
- Start
- Oct 2010
- Primary completion
- Sep 2015
- Countries
- 1
01
Overview
A Phase 2 trial of KL-140 in colorectal cancer (CRC), peritoneal carcinomatosis (PC), sponsored by University of Regensburg. Started Oct 2010; status: terminated.
02
Drugs
KL-140
03
Conditions
colorectal cancer (CRC)peritoneal carcinomatosis (PC)
Beyond the preview
Go deeper on NCT01540344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01540344.